Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 4/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18875411 | 0.83 | OPRD1 (0.43) | OPRD1LTA4HSIGMAR1ALDH1A1L3MBTL1 | |
| SCHEMBL18878756 | 0.80 | SIGMAR1 (0.38) | OPRD1LTA4HSIGMAR1ALDH1A1HTT | |
| SCHEMBL18875651 | 0.79 | OPRD1 (0.48) | OPRD1LTA4HSIGMAR1L3MBTL1LMNA | |
| SCHEMBL18875654 | 0.79 | OPRD1 (0.48) | OPRD1LTA4HSIGMAR1L3MBTL1LMNA | |
| SCHEMBL18878632 | 0.77 | LTA4H (0.39) | OPRD1LTA4HSIGMAR1ALDH1A1L3MBTL1 | |
| SCHEMBL18875429 | 0.74 | OPRD1 (0.45) | OPRD1LTA4HSIGMAR1ALDH1A1HTT | |
| SCHEMBL18875624 | 0.74 | OPRD1 (0.45) | OPRD1LTA4HSIGMAR1ALDH1A1HTT | |
| SCHEMBL18875512 | 0.74 | OPRD1 (0.45) | OPRD1LTA4HSIGMAR1ALDH1A1HTT | |
| SCHEMBL18875321 | 0.74 | OPRD1 (0.45) | OPRD1LTA4HSIGMAR1ALDH1A1HTT | |
| SCHEMBL18875398 | 0.74 | OPRD1 (0.45) | OPRD1LTA4HSIGMAR1ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | OPRD1 1464/4885LTA4H 1125/4885SIGMAR1 2900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.